Cannabis Rescheduling: A Structural Shift, Not a Silver Bullet
What Moving Cannabis from Schedule I to Schedule III Really Means for Operators, Investors, and Medical Markets Cannabis rescheduling is no longer a theoretical policy debate. It is now an active federal process with material implications for how cannabis businesses are taxed, valued, financed, and regulated. Moving cannabis from Schedule I to Schedule III under […]